NFA
KPTI icon

Nationwide Fund Advisors’s Karyopharm Therapeutics KPTI Stock Holding History

Nationwide Fund Advisors’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,044
Closed -$1.16M – 1109
2017
Q3 		$1.16M Buy
7,044
+5,624
+396% +$806K ﹤0.01% 1702
2017
Q2 		$193K Sell
1,420
-2,348
-62% -$348K ﹤0.01% 2636
2017
Q1 		$726K Buy
3,768
+2,402
+176% +$386K ﹤0.01% 1942
2016
Q4 		$193K Buy
1,366
+341
+33% +$46.1K ﹤0.01% 2618
2016
Q3 		$150K Sell
1,025
-392
-28% -$47.1K ﹤0.01% 2765
2016
Q2 		$143K Buy
1,417
+392
+38% +$50.9K ﹤0.01% 2765
2016
Q1 		$137K Hold
1,025
– – ﹤0.01% 2702
2015
Q4 		$204K Buy
1,025
+31
+3% +$6.71K ﹤0.01% 2548
2015
Q3 		$157K Hold
994
– – ﹤0.01% 2691
2015
Q2 		$406K Buy
994
+270
+37% +$117K ﹤0.01% 2362
2015
Q1 		$332K Buy
724
+34
+5% +$14.7K ﹤0.01% 2451
2014
Q4 		$388K Hold
690
– – ﹤0.01% 2331
2014
Q3 		$361K Buy
690
+57
+9% +$32.2K ﹤0.01% 2402
2014
Q2 		$442K Sell
633
-40
-6% -$18.6K ﹤0.01% 2328
2014
Q1 		$312K Sell
673
-176
-21% -$89.2K ﹤0.01% 2289
2013
Q4 		$292K Buy
+849
New +$235K ﹤0.01% 2496

Other funds holding KPTI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Nationwide Fund Advisors's KPTI Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Karyopharm Therapeutics (KPTI) in Q4 2017, closing a stake of 7,044 shares — an estimated $1.16M sold.

Nationwide Fund Advisors first reported a position in KPTI in Q4 2013 and held it in 16 quarters. The position peaked at $1.16M in Q3 2017. 90 funds tracked by Wall St. Rank hold KPTI as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Karyopharm Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 7,044 Karyopharm Therapeutics shares in Q4 2017, an estimated $1.16M.
  • Nationwide Fund Advisors first reported a position in Karyopharm Therapeutics in Q4 2013 and held it in 16 quarters.
  • Nationwide Fund Advisors's Karyopharm Therapeutics position peaked at $1.16M in Q3 2017.
  • 90 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.